A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

An important clinical trial for Parkinson’s disease has just gotten underway in the UK. The placebo-controlled Phase III trial will test whether a long-existing cough medication can slow down ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

Common cough medicine could slow dementia in Parkinson’s patients, study hints Cough medicine widely used in Europe remains unapproved for use in US, Canada, researchers say Vishwam Sankaran ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...